HIGHLIGHTS
- who: Pan Yu and collaborators from the College of Medicine, Anhui University of Science and Technology, Huainan, China have published the article: Design, Synthesis, and Antitumor Evaluation of Novel Mono-Carbonyl Curcumin Analogs in Hepatocellular Carcinoma Cell, in the Journal: Pharmaceuticals 2022, 950 of 22/06/2022
- what: The authors attempt to design new curcumin analogs modified on the u03b2-diketone structure and hydroxy on benzene to increase the anti-human hepatocellular carcinoma (HCC) activity. As shown in Figure 1A, curcumin analogs in group B and group C showed stronger anti-proliferation activities than groups . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.